Contribution of tumor markers to pretreatment staging of operable lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 360s Year: 2003
Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease Source: Eur Respir J 2014; 43: 1439-1447 Year: 2014
Prognostic parameters in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006
Prognostic significance of tumour-related factors in resectable nonsmall-cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001
Analysis of surgical stage lung cancer and tumour markers prognostic value Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006
Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002
Prognostic value of Her2/neu in stage IIIA non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006
The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Time in lung cancer diagnosis and its prognostic implication Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
Prognostic value of microRNAs profiling in early stage squamous cell lung cancer Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009
Prognostic factors affecting survival in advanced non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008
Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012
Prognostic factors in patients with lung cancer and brain metastases at presentation Source: Eur Respir J 2007; 30: Suppl. 51, 670s Year: 2007
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK -rearranged non-small cell lung cancer Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017 Year: 2018
Hypoxia-response gene signatures as predictive and prognostic biomarkers in advanced non-squamous non-small cell lung cancer patients Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006
The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010